Get the facts about CAYSTON

  • Fights Pa at the source

    Fights Pa at the source
  • Provided results you can feel and your doctor can measure

    Provided results you can feel and your doctor can measure

    In a clinical trial, patients taking CAYSTON for 28 days reported improved breathing symptoms, such as cough, wheezing, and mucus production. Patients taking CAYSTON also had an average 10% increase of their starting FEV1 compared to patients in the placebo group. This difference decreased to about 6% 2 weeks after stopping CAYSTON.

  • Common side effects

    Common side effects

    The most common side effects of CAYSTON include cough, nasal congestion, wheezing, sore throat, fever (may be more common in children than in adults), chest discomfort, stomach area (abdominal) pain, and vomiting.

  • Offers fast treatment time and flexible dosing

    Offers fast treatment time and flexible dosing
  • Allows you to take treatments on the go

    Allows you to take treatments on the go
  • Talk to your doctor about whether CAYSTON may be right for you.

Learn more about CAYSTON
What is CAYSTON?

CAYSTON is a prescription inhaled antibiotic used to improve breathing symptoms in people with cystic fibrosis (CF) who have a lung infection due to Pseudomonas aeruginosa (Pa). CAYSTON is not a treatment for infections caused by other bacteria or viruses, such as the common cold. CAYSTON is used only with the Altera® Nebulizer System. It is not known if CAYSTON is safe and effective in children under the age of 7 or in patients with FEV1 <25% or >75% predicted.